Registration for this event has been disabled.

***NEW DATES ANNOUNCED: 1-2 April 2025***


BioTrinity 2025 - Convene 133 Houndsditch, London


Following overwhelmingly positive feedback from BioTrinity 2024, OBN are pleased to announce that the 2025 edition will again be hosted in Convene 133 Houndsditch in London on a new date of 1 & 2 April 2025. 


About BioTrinity:


BioTrinity is OBN's flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The two-day conference programme for 2025 will feature a dual track of showcase presentations from R&D companies at around the Series A stage, across at least 12 different therapy areas, a packed business & investment track, sponsors exhibition, networking events, private partnering meetings and an academic poster presentation. Themes, Presenters and a more detailed programme to be announced from the end of Summer 2024. 


After another sell-out year in 2024, we expect an expanded and refreshed audience of 850 delegates to attend BioTrinity 2025, comprising a mix of early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.


As ever, there will be plenty of different ways to get involved, so if you are interested in potential sponsorship, group delegation options, session sponsorship and speaking opportunities, please email the team at events@obn.org.uk.